Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Kendall Keith J Create: Alert

All | News | Filings
Date FiledTypeDescription
06/16/2023 4 Kendall Keith J (Director) has filed a Form 4 on FEMASYS INC
Txns: Granted 17,000 options to buy @ $0.64, valued at $10.9k
03/14/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/27/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/15/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/04/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/02/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/05/2020 4 Kendall Keith J (CEO and President) has filed a Form 4 on Aquestive Therapeutics, Inc.
Txns: Sold 50,000 shares @ $5.1062, valued at $255.3k
06/02/2020 4 Kendall Keith J (CEO and President) has filed a Form 4 on Aquestive Therapeutics, Inc.
Txns: Paid exercise price by delivering 6,492 shares @ $4.87, valued at $31.6k
Exercised 14,572 restricted stock units @ $0
04/02/2020 4 Kendall Keith J (CEO and President) has filed a Form 4 on Aquestive Therapeutics, Inc.
Txns: Paid exercise price by delivering 99 shares @ $2.19, valued at $216.8
Exercised 329 restricted stock units @ $0
03/18/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/03/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/02/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/02/2019 4 Kendall Keith J (CEO and President) has filed a Form 4 on Aquestive Therapeutics, Inc.
Txns: Paid exercise price by delivering 14,572 shares @ $7.79, valued at $113.5k
Exercised 14,572 restricted stock units @ $0
10/02/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/03/2019 4 Kendall Keith J (CEO and President) has filed a Form 4 on Aquestive Therapeutics, Inc.
Txns: Paid exercise price by delivering 6,676 shares @ $3.8, valued at $25.4k
Exercised 14,572 restricted stock units @ $0
08/20/2019 4 Kendall Keith J (CEO and President) has filed a Form 4 on Aquestive Therapeutics, Inc.
Txns: Bought 2,000 shares @ $3.84, valued at $7.7k
Bought 1,000 shares @ $3.925, valued at $3.9k
Bought 2,000 shares @ $3.995, valued at $8k
Bought 1,000 shares @ $4.045, valued at $4k
Bought 1,000 shares @ $3.697, valued at $3.7k
Bought 1,000 shares @ $3.65, valued at $3.7k
07/02/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/03/2019 4 Kendall Keith J (CEO and President) has filed a Form 4 on Aquestive Therapeutics, Inc.
Txns: Paid exercise price by delivering 6,780 shares @ $3.72, valued at $25.2k
Exercised 14,572 restricted stock units @ $0
04/01/2019 4 Kendall Keith J (CEO and President) has filed a Form 4 on Aquestive Therapeutics, Inc.
Txns: Paid exercise price by delivering 263 shares @ $6.91, valued at $1.8k
Exercised 329 restricted stock units @ $0
03/04/2019 4 Kendall Keith J (CEO and President) has filed a Form 4 on Aquestive Therapeutics, Inc.
Txns: Granted 325,000 options to buy @ $8.05, valued at $2.6M
03/01/2019 4 Kendall Keith J (CEO and President) has filed a Form 4 on Aquestive Therapeutics, Inc.
Txns: Paid exercise price by delivering 4,725 shares @ $8.05, valued at $38k
Exercised 14,572 restricted stock units @ $0
01/03/2019 4 Kendall Keith J (CEO and President) has filed a Form 4 on Aquestive Therapeutics, Inc.
Txns: Paid exercise price by delivering 162 shares @ $6.3, valued at $1k
Exercised 329 restricted stock units @ $0
12/04/2018 4 Kendall Keith J (CEO and President) has filed a Form 4 on Aquestive Therapeutics, Inc.
Txns: Paid exercise price by delivering 7,177 shares @ $8.59, valued at $61.7k
Exercised 14,572 restricted stock units @ $0
11/28/2018 4 Kendall Keith J (CEO and President) has filed a Form 4 on Aquestive Therapeutics, Inc.
Txns: Bought 1,000 shares @ $9.87, valued at $9.9k
11/26/2018 4 Kendall Keith J (CEO and President) has filed a Form 4 on Aquestive Therapeutics, Inc.
Txns: Bought 6,000 shares @ $10.17, valued at $61k
Bought 1,950 shares @ $9.9, valued at $19.3k
10/02/2018 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/05/2018 4 Kendall Keith J (CEO and President) has filed a Form 4 on Aquestive Therapeutics, Inc.
Txns: Paid exercise price by delivering 6,510 shares @ $18.01, valued at $117.2k
Exercised 14,572 restricted stock units @ $0
08/17/2018 4 Kendall Keith J (CEO and President) has filed a Form 4 on Aquestive Therapeutics, Inc.
Txns: Granted 28,043 options to buy @ $16.46, valued at $461.6k
Granted 2,636 restricted stock units @ $0
07/26/2018 4 Kendall Keith J (CEO and President) has filed a Form 4 on Aquestive Therapeutics, Inc.
Txns: Granted 240,165 options to buy @ $15, valued at $3.6M
Granted 116,576 restricted stock units @ $0

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy